NCT01531166View on ClinicalTrials.gov

A Cohort Study in Korean Patients With Chronic Hepatitis B (CHB) Receiving Pegylated Interferon

CompletedOBSERVATIONAL
Enrollment

500

Participants

Timeline

Start Date

September 30, 2011

Primary Completion Date

August 31, 2014

Study Completion Date

October 31, 2014

Conditions
Chronic Hepatitis B
Interventions
DRUG

pegylated Interferon-alpha 2a

Pegasys 180mcg/PFS/ subcutaneous injection / Once a week

Trial Locations (1)

120-752

Sang Hoon Ahn, Seoul

All Listed Sponsors
lead

Yonsei University

OTHER

NCT01531166 - A Cohort Study in Korean Patients With Chronic Hepatitis B (CHB) Receiving Pegylated Interferon | Biotech Hunter | Biotech Hunter